Sponsor LifeSci Holdings has committed to purchase 3,033,333 warrants at 90 cents per warrant for an aggregate purchase price of $2.7 million. The SPAC said it is targeting companies in North America or Europe that are developing assets in the biopharma, medical technology, digital health, and healthcare services sectors. Read more.
Related Posts
Nabors Energy Transition Shareholders Approve up to 4-Month Extension; Redmptions Hit 26%
The SPAC has a merger agreement in place with Australia-based Vast Solar.
CC Neuberger Principal Holdings II Restates Financials for New Accounting on Warrants
In its review of the matter, the SPAC said because its warrants include a cash settlement feature that could arise in certain events, such as a tender or exchange offer accepted by more than 50 percent of shareholders, shifting warrants to the liabilities side of the balance sheet was the prudent move.
GigCapital5 Registers for $350M IPO
The latest GigCapital SPAC intends to target companies around the world focused on digital transformation, aerospace, intelligent automation, and sustainability.
XPAC Acquisition Sponsors Sell Stake to New Management Ahead of Extension Vote
XPAC will be renamed Zalatoris II Acquisition and a July 27 meeting is set to approve these changes as well as a deadline extension in monthly increments until Aug. 3, 2024 without further contributions to the SPAC’s trust.